Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial
Titel:
Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial
Auteur:
Herbst, Roy S Ansari, Rafat Bustin, Frederique Flynn, Patrick Hart, Lowell Otterson, Gregory A Vlahovic, Gordana Soh, Chang-Heok O'Connor, Paula Hainsworth, John